Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medirom Healthcare Technologies (MRM) Receivables (2019 - 2024)

Historic Receivables for Medirom Healthcare Technologies (MRM) over the last 6 years, with Q4 2024 value amounting to $8.7 million.

  • Medirom Healthcare Technologies' Receivables rose 9238.75% to $8.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.7 million, marking a year-over-year increase of 9238.75%. This contributed to the annual value of $8.7 million for FY2024, which is 9238.75% up from last year.
  • According to the latest figures from Q4 2024, Medirom Healthcare Technologies' Receivables is $8.7 million, which was up 9238.75% from $4.5 million recorded in Q4 2023.
  • Over the past 5 years, Medirom Healthcare Technologies' Receivables peaked at $8.7 million during Q4 2024, and registered a low of -$3.1 million during Q4 2022.
  • For the 5-year period, Medirom Healthcare Technologies' Receivables averaged around $3.6 million, with its median value being $3.4 million (2022).
  • In the last 5 years, Medirom Healthcare Technologies' Receivables soared by 56332.48% in 2020 and then crashed by 14072.09% in 2022.
  • Quarter analysis of 5 years shows Medirom Healthcare Technologies' Receivables stood at $2.8 million in 2020, then skyrocketed by 164.65% to $7.5 million in 2021, then crashed by 140.72% to -$3.1 million in 2022, then soared by 246.89% to $4.5 million in 2023, then soared by 92.39% to $8.7 million in 2024.
  • Its Receivables stands at $8.7 million for Q4 2024, versus $4.5 million for Q4 2023 and -$3.1 million for Q4 2022.